[Effects of chronic inhibition of adipocyte phosphodiesterase on lipolysis induced with noradrenaline in normal and obese subjects].
D000273:Adipose Tissue / Q000201:enzymology* / Q000378:metabolism; D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005419:Flavonoids / Q000494:pharmacology*; D005422:Flavoxate / Q000494:pharmacology*; D005990:Glycerol / Q000097:blood; D006801:Humans; D007328:Insulin / Q000097:blood; D050356:Lipid Metabolism; D008066:Lipolysis / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000494:pharmacology*; D009765:Obesity / Q000378:metabolism*; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D005419:Flavonoids; D007328:Insulin; D010726:Phosphodiesterase Inhibitors; D005422:Flavoxate; D010727:Phosphoric Diester Hydrolases; D005990:Glycerol; D009638:Norepinephrine
Effetti dell'inibizione cronica della fosfodesterasi adipocitaria sulla lipolisi da noradrenalina in soggetti normali ed obesi.